| ||
| ||
| Rexahn Pharmaceuticals Publishes New Data on Anti-Cancer Isoquinolinamine ... MarketWatch (press release) Last month Rexahn announced the publication of new preclinical data in Bioorganic & Medicinal Chemistry Letters demonstrating that RX-8243, ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment